Comment citer
Résumé
Introduction
Sickle cell disease (SCD) remains a major public health challenge in Mbandaka, Democratic Republic of the Congo, yet its clinical and epidemiological characteristics are insufficiently studied.
Purpose
This study aims to describe the prevalence, clinical profiles, and treatment outcomes of SCD in children treated at Wangata General Referral Hospital.
Methods
A retrospective review of medical records for children aged 2 months to 15 years hospitalised between January 2017 and December 2023 was conducted. Data were analysed using Epi Info version 7.2.5.0.
Results
Among 4,492 paediatric admissions, 64 cases of SCD were identified, yielding a prevalence of 1.4%. The case-fatality rate was 20.3%, with complications such as malaria and sepsis contributing to deaths. Hydroxyurea, a standard therapeutic agent, was not administered to any patient. The average length of hospitalisation was 3.5 days, and most deaths (53.8%) occurred within 48 hours of admission.
Conclusion
SCD in Wangata is characterised by low prevalence but high mortality, reflecting gaps in diagnosis, treatment, and hospital resources. Urgent measures are needed to improve awareness, healthcare provider training, and access to essential medications.
Références
Bitwe, R., Schirvel, C., Dramaix, M., & Hennart, P. (2009). Impact of a quality of care training and supervision programme on in-hospital mortality of care on in-hospital child mortality in Central Africa. Public Health, 21(4), 415–426.
Cally, R., Benarous, L., Ete, M., Patient, M., Martin, A., Ebbo, M., Mazodier, K., Poullin, P., Harlé, J. R., Schleinitz, N., Thuret, I., & Bernit, E. (2015). The causes of death in sickle cell anaemia patients: A single-centre monocentric study of the Marseille cohort. Revue de Médecine Interne, 36(Suppl 2), A133.
Chemegni, C. B., Ola’a Bamzok, E. K., Ngo Sack, F., Ngouadjeu, E., & Mbanya, D. (2018). Morbidity and mortality in sickle cell patients at the haematology department of Yaoundé Central Hospital. Health Sciences and Disease, 19(1 Suppl).
Cissouma, A., Traoré, M., Kassogué, D., Poma, H., Sangaré, A., Traoré-Kissima, A., Keita, I., Kelema, P., Diakité, A. A., Traoré, S. A., & Coulibaly, M. B. (2021). Epidemiological and clinical aspects of sickle cell disease in children at Sikasso Hospital. Health Sciences and Disease, 22(9), 57–60.
Dahmani, F., Benkirane, S., Kouzih, J., Woumki, A., Mamad, H., & Masrar, A. (2017). Epidemiological profile of haemoglobinopathies: Descriptive cross-sectional study of the index case. Pan African Medical Journal, 27, 150. https://doi.org/10.11604/pamj.2017.27.150.11477
Dodo, R., Zohoun, A., Baglo, T., Mehou, J., & Anani, L. (2018). Sickle cell disease emergencies at the Blood Disease Department of the National University Hospital Center-Hubert Koutoukou Maga in Cotonou, Benin. Pan African Medical Journal, 30, 192.
Eleke Ebola, H. S., Bwana Kambale, T., Tshilolo, L., Wembonyama Okitotsho, S., & Eloko Eya Matangelo, G. (2024). Genetic epidemiology of sickle cell disease and evaluation of its relationships with malaria and anemia: Case of children aged 0 to 60 months from Mbandaka, DR Congo. International Journal of Scientific and Development Research, 9(9), 45–52.
Koko, J., Dufillot, D., M'Ba-Meyo, J., Gahouma, D., & Kani, F. (1998). Child mortality in sickle cell patients in the paediatric department in Central Africa. Archives of Pediatrics, 5, 965–969.
Mbiya Mukinayi, B., Kalombo Cibeyibeyi, G., Disashi Tumba, G., & Gulbis, B. (2021). Sickle cell disease in the Democratic Republic of Congo: What are the obstacles to treatment with hydroxyurea? Pan African Medical Journal, 38(41). https://doi.org/10.11604/pamj.2021.38.41.18718
Odièvre, M.-H., & Quinet, R. (2022). Sickle cell disease in children. Journal of Pediatrics and Puericulture, 35(2), 73–92.
Ouédraogo-Yugbaré, S. O., Tiendrebeogo, J., Koueta, F., Sawadogo, H., Dao, L., Ouédraogo, P., Kaboret, S., Kam, M., Kam, K. L., Yé, D., & Simporé, J. (2014). Major sickle cell syndromes in children aged 0 to 15 years in Ouagadougou: Genetic markers and clinical characteristics. Pan African Medical Journal, 19, 215. https://doi.org/10.11604/pamj.2014.19.215.3460
Ranivoson, A. H., Andriatahina, T. N., Ratsimbazafy, A. B. A., Rabesandratana, H. M. M., & Robinson, A. L. (2019). Infectious complications of sickle cell patients in paediatrics and their risk factors. Revue Malgache de Pédiatrie, 2(1), 75–81.
Seck, N., Bop, K., Mbacke, O., Diagne, I., Thiam, L., Ndongo, A. A., Keïta, Y., Basse, I., Boiro, D., & Sow, A. (2021). Major sickle cell syndromes in children and adolescents: Study of the cohort of the Regional Hospital Center of Saint-Louis (Senegal). European Scientific Journal, 17(34), 70. https://doi.org/10.19044/esj.2021.v17n34p70
Shongo ya Pongombo, M. (2022). Sickle cell disease in the DRC: Burden of a heavier price. Revue de Médecine et de Santé Publique, 5(1), 30–33.
Tewari, S., Brousse, V., Piel, F. B., Menzel, S., & Rees, D. C. (2014). Environmental determinants of sickle cell disease severity. Haematologica, 100(9), 1108–1116. https://doi.org/10.3324/haematol.2014.120030
Tshilolo, L., & Aissi, L. M. (2009). Practical guide to early diagnosis and management of sickle cell disease in the DRC. Health Support, Training and Monitoring Platform on Sickle Cell Disease “PAFOVED”. CEFA. Kinshasa.
Tshilolo, L., Aissi, L. M., Lukusa, D., Kinsiama, C., Wembonyama, S., Gulbis, B., & Vertongen, F. (2009). Neonatal screening for sickle cell disease in the Democratic Republic of the Congo: Experience from a pioneer project on 31,204 newborns. Journal of Clinical Pathology, 62(1), 35–38.
Wailoo, K. (2017). Sickle cell disease: A history of progress and peril. New England Journal of Medicine, 376, 805–807
Ce travail est disponible sous licence Creative Commons Attribution - Pas d’Utilisation Commerciale 4.0 International.